25 of the Best Pediatricians Near Me in Clinton,, MD

Dr. Julie Hoover-Fong is a Professor of Genetic Medicine and Pediatrics and Director of the Greenberg Center for Skeletal Dysplasias at Johns Hopkins University. Dr. Hoover-Fong holds a bachelor’s degree in Human Nutrition from The Ohio State University, where she also completed her medical degree. She received her Ph.D. in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Hoover-Fong completed a pediatric internship and residency at Washington University in St. Louis and a fellowship in medical genetics at Johns Hopkins University in Baltimore. She joined the Johns Hopkins University faculty in 2002 and progressed to Professor of Genetic Medicine and Pediatrics in 2019. She practices and oversees the clinical operations, research and educational ventures for the patients, families and healthcare providers served by the Greenberg Center. Her clinical team develops and improves diagnostic and treatment guidelines for comprehensive care of patients with all types of bone conditions including dwarfism, orofacial clefting, craniosynostosis and more. Dr. Hoover-Fong also mentors and teaches medical students, residents and genetic medicine trainees. As an active clinical researcher, Dr. Hoover-Fong is the Principal Investigator of multiple global clinical trials for achondroplasia, the first multi-center, investigator-initiated natural history study for achondroplasia, and multiple clinical studies for patients with orofacial clefting, hypophosphatasia and other conditions. She is also a co-investigator on the ELSI and Phenotype Review Committees for the Mendel Project, a whole exome sequencing venture to identify the genetic cause of Mendelian conditions. From an institutional service perspective, Dr. Hoover-Fong serves on the Johns Hopkins Associate Professor Promotions Committee and the Advisory Committee for the Graduate Training Program in Clinical Investigation. She serves on the Medical Advisory Board of the Little People of America, is a member of the Miller-Coulson Academy of Clinical Excellence at Johns Hopkins University and is a charter member of the International Skeletal Dysplasia Management Consortium, publishing best practice guidelines for patients with skeletal dysplasias. Dr. Hoover-Fong is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Achondroplasia, Rhizomelic Syndrome, Spondyloepimetaphyseal Dysplasia Strudwick Type, Adenoidectomy, and Myringotomy. Dr. Hoover-Fong is board certified in American Board Of Medical Genetics And Genomics. Dr. Hoover-Fong is currently accepting new patients.

Dr. Gerald Raymond is a clinical geneticist and neurologist at Johns Hopkins where he is also a professor of genetic medicine and neurology. He obtained his MD at the University of Connecticut and was trained in Pediatrics at Johns Hopkins Hospital and Neurology at the Mass. General Hospital. He received additional training in developmental neuropathology at the Universite Catholique de Louvain in Belgium and clinical genetics at the Harvard Program. Dr. Raymond’s research has been at the overlap of genetics and neurology with specific focus on peroxisomal disorders including adrenoleukodystrophy. He has been actively involved in newborn screening for ALD and in developing clinical follow-up programs. He has extensive experience in clinical management of neurogenetic issues including peroxisomal and lysosomal disorders. He presently serves as the Director of the Lysosomal Storage Disease program in the department of Genetic Medicine. Dr. Raymond is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Adrenoleukodystrophy (ALD), Zellweger Syndrome, Leukodystrophy, and Jacobsen Syndrome. Dr. Raymond is board certified in American Board Of Psychiatry And Neurology and American Board Of Medical Genetics And Genomics. Dr. Raymond is currently accepting new patients.

Dr. Christine Pratilas is a pediatric medical oncologist at the Sidney Kimmel Comprehensive Cancer Center and Associate Professor of Oncology, Pediatrics & Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine. She joined the Hopkins pediatric sarcoma team in 2014. Dr. Pratilas received her undergraduate degree in Biology from Drew University in New Jersey and her medical degree from UMDNJ - Robert Wood Johnson Medical School (now Rutgers University), where she also completed her internship and residency from 1999 to 2002. From 2002 to 2005 she was a fellow in hematology and oncology in the Memorial Sloan Kettering Cancer Center (MSKCC) Department of Pediatrics, and in the Department of Pediatric Hematology and Oncology at New York Weill Cornell Medical Center. She was a postdoctoral research fellow in Dr. Neal Rosen’s Molecular Oncogenesis Laboratory at MSKCC. From 2006 to 2014 she was attending in Pediatric Oncology at MSKCC, specializing in developmental therapeutics & sarcoma. She has been the director of the pediatric sarcoma program at Hopkins since 2018. Dr. Pratilas focuses her research on cancer-associated pathways and signal transduction, which involves figuring out how a cell’s internal molecular pathways work, and how those pathways can be molecularly controlled. This knowledge is the basis for developing promising new molecularly targeted cancer therapies, which is the focus of Dr. Pratilas’s research. Among her important scientific contributions is advancing our understanding of how certain proteins that can be mutated in cancer, known as RAF kinases (specifically BRAF), affect a cancer cell’s behavior. The research in Dr. Pratilas' laboratory is focused on RAS signal transduction pathways, concentrating on pediatric sarcomas such as rhabdomyosarcoma and malignant peripheral nerve sheath tumors, in order to develop novel therapeutics for children with these tumors. Dr. Pratilas is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Osteotomy. Dr. Pratilas is board certified in American Board Of Pediatrics. Dr. Pratilas is currently accepting new patients.

Carl E. Stafstrom is a pediatric neurologist, caring for children with epilepsy. Dr. Stafstrom received his medical degree from the University of Washington School of Medicine in Seattle, with residencies at the University of Washington Medical Center and Tufts New England Medical Center, as well as fellowships at Harvard for neurology research and Boston Children’s Hospital in clinical neurophysiology, electroencephalography, and epilepsy. Dr. Stafstrom previously served as Professor of Neurology and Pediatrics at the University of Wisconsin-Madison School of Medicine and Public Health and Chief of Pediatric Neurology at American Family Children’s Hospital at UW Madison. Dr. Stafstrom is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, West Syndrome, Juvenile Myoclonic Epilepsy, and Endovascular Embolization. Dr. Stafstrom is board certified in American Board Of Psychiatry And Neurology. Dr. Stafstrom is currently accepting new patients.

Catherine Chu is the director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center in the Johns Hopkins Department of Neurology, as well as the vice president of child neurology at the Kennedy Krieger Institute. As a child neurologist, epileptologist and clinical neurophysiologist, Dr. Chu cares for children diagnosed with epilepsy and disorders of the nervous system (neurophysiology). She specializes in electroencephalogram (also known as EEG) analysis, seizure localization, surgical planning and neuromodulation for adult and pediatric patients with difficult to control epilepsy. She is nationally and internationally recognized for her work identifying causes of and treatment options for cognitive dysfunction and seizures in epilepsy and neurodevelopmental disorders. Dr. Chu’s team specializes in identifying and developing tools to detect and understand brain rhythms that support complex cognitive functions throughout development, including how these rhythms are disrupted by seizures and neurodevelopmental disorders. Dr. Chu earned her medical degree and a master’s degree in social anthropology from Harvard University. She completed an internship in pediatrics at Massachusetts General Hospital, and then a residency in neurology and child neurology at Massachusetts General and Brigham and Women’s Hospital. After completing two fellowships at Massachusetts General, one in epilepsy and another in clinical neurophysiology, Dr. Chu earned a master’s degree in medical science, focused on clinical investigation, from Harvard Medical School. Dr. Chu is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Benign Rolandic Epilepsy, Epilepsy in Children, Seizures, Epilepsy, and Deep Brain Stimulation. Dr. Chu is board certified in American Board Of Psychiatry And Neurology. Dr. Chu is currently accepting new patients.

Dr. Jill A. Fahrner is an assistant professor in the Departments of Genetic Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her area of clinical expertise is medical genetics. Dr. Fahrner earned her Ph.D. from Johns Hopkins University and her M.D. from the University of North Carolina. She completed pediatrics residency training at Duke University Medical Center. She joined the McKusick-Nathans Institute of Genetic Medicine as a genetic medicine resident in 2009 and completed her training in 2012. She stayed on as chief resident from 2012-2013 and then joined the faculty as an assistant professor in the Department of Pediatrics within the McKusick-Nathans Institute of Genetic Medicine in 2013. Her current primary appointment is Assistant Professor in the Department of Genetic Medicine, where she is Director of the multidisciplinary Epigenetics and Chromatin Clinic. She is a physician-scientist with a long-standing interest in epigenetic mechanisms of disease. Her clinical focus is on caring for individuals with epigenetic and chromatin disorders, specifically Mendelian disorders of the epigenetic machinery, or chromatin modifying disorders. She has seen hundreds of individuals with congenital disorders involving disrupted epigenetics, most of which exhibit neurodevelopmental disabilities and abnormal growth. Her laboratory research is focused on understanding disease mechanisms and developing therapies for select Mendelian disorders of the epigenetic machinery. She is a member of the American Society of Human Genetics (ASHG), having won an ASHG Reviewer’s Choice Abstract Award for her work on growth retardation in Kabuki syndrome 1. She has received a Johns Hopkins School of Medicine Clinician Scientist Award, a Johns Hopkins School of Medicine Musculoskeletal Pilot and Feasibility Award, a William and Ella Owens Medical Research Foundation Award, the Margaret Ellen Nielsen Fellowship Award, and the Alice and YT Chen Travel Award while at Johns Hopkins. She is the recipient of a prestigious Hartwell Foundation Individual Biomedical Research Award and also has ongoing research funding from the National Institutes of Health. Dr. Fahrner is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Weaver Syndrome, Sotos Syndrome, Kabuki Syndrome, Marshall-Smith Syndrome, and Orchiectomy. Dr. Fahrner is board certified in American Board Of Medical Genetics And Genomics. Dr. Fahrner is currently accepting new patients.

Dr. Wikrom Karnsakul is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical interests are in the care of pediatric liver diseases, and general gastrointestinal diseases. Dr. Karnsakul received his medical degree in 1992 from Faculty of Medicine, Siriraj Medical Center, Mahidol University School of Medicine in Bangkok, Thailand. He completed his residency in pediatrics at Advocate Hope Children's Hospital in 1998 and did a fellowship in pediatric gastroenterology, hepatology and nutrition at Texas Children's Hospital, Baylor College of Medicine in Houston, Texas. He completed his postdoctoral research training at USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine. He joined the faculty at Johns Hopkins in 2008. His research interests center on the understanding and treatment of chronic liver disease, ascites, cholestasis, viral hepatitis especially hepatitis C and hepatitis E, and Cystic Fibrosis Related Liver Disease. Dr. Karnsakul is also involved in NIH-funded multicenter research studies including the Cholestatic Liver Disease Consortium and Cystic Fibrosis Related Liver Disease Project. Dr. Karnsakul is currently a Fellow of the American Association for the Study of Liver Diseases (FAASLD). Dr. Karnsakul is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Alagille Syndrome, Cholestasis, Ascites, Liver Transplant, and Endoscopy. Dr. Karnsakul is board certified in American Board Of Pediatrics. Dr. Karnsakul is currently accepting new patients.

Dr. Heather Noelle Di Carlo is an associate professor of urology at the Johns Hopkins University School of Medicine. She treats all pediatric urological disorders in young males and females while specializing in renal sparing surgery and complex reconstruction of the genitourinary tract in patients with the exstrophy-epispadias complex, disorders of sexual development (DSD) and other congenital anomalies. She serves as the Director of Pediatric Urology Research and is the interim Division Director of Pediatric Urology. A native of New York, Dr. Di Carlo graduated from Emory University with a B.S. in neuroscience and music, and the State University of New York at Stony Brook School of Medicine. Following general surgery and urology residency training at Stony Brook Medical Center, she completed a pediatric urology fellowship at the James Buchanan Brady Urological Institute. Dr. Di Carlo has special clinical and basic science interests in the exstrophy-epispadias complex, spina bifida and renal transplantation. Dr. Di Carlo is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Exstrophy-Epispadias Complex, Cloacal Exstrophy, Epispadias, Bladder Reconstruction, and Osteotomy. Dr. Di Carlo is board certified in American Board Of Urology. Dr. Di Carlo is currently accepting new patients.

Ambroise Wonkam is a Pediatrics specialist and a Medical Genetics provider practicing medicine in Baltimore, Maryland. Dr. Wonkam is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Anemia, Fragile X Syndrome, and Micrognathia. Dr. Wonkam is currently accepting new patients.

Dr. Habela completed a Medical Scientist Training Program at the University of Alabama, Birmingham. She received her PhD in Neurobiology in 2008 and her MD in 2010. After medical school, she specialized in child neurology, and completed 2 years of pediatrics residency and 3 years of child neurology residency at the Johns Hopkins Hospital in 2015. She then completed another 2 years of training specifically focused on the diagnosis, characterization and medical and surgical management of patients with epilepsy during an Epilepsy Fellowship at Johns Hopkins. Dr. Habela’s clinic specializes in pediatric neurology and epilepsy. Her clinical focus in on the care of patients with severe epilepsy with or without other neurodevelopmental disorders that have not been easily controlled with medications. She is also focused on the genetic causes of epilepsy and other neurodevelopmental disabilities with the hope that increasing our understanding of the genetic causes of epilepsy and neurodevelopmental disabilities will improve treatment. Dr. Habela’s basic science research is focused on the genetic mechanisms regulating appropriate proliferation, migration and integration of neurons and glial cells in both the prenatal and postnatal developing brain and how aberrations in these processes result in neurodevelopmental disabilities. Her hypothesis is that deregulation of pre and postnatal neurogenesis and synaptogenesis contributes to the behavioral phenotypes observed in many forms of intellectual disability, epilepsy and autism. Her research applies what we know from human genetic studies to basic science studies examining how specific genetic changes alter neurogenesis, synaptogenesis and overall excitation / inhibition balance in laboratory model systems. Her goal is to provide a better understanding of the molecular mechanisms of these processes and, in turn, possibly identify specific targets for disease modifying treatments for epilepsy. Contact for Research Inquiries 600 N. Wolfe Street Meyer 2-147 Baltimore, MD 21287 Phone: (410) 955-9100. Dr. Habela is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Epilepsy, and Endovascular Embolization. Dr. Habela is board certified in American Board Of Psychiatry And Neurology. Dr. Habela is currently accepting new patients.

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Amblyopia, Retinopathy of Prematurity, Ocular Hypertension (OHT), Cataract Removal, and Vitrectomy. Dr. Repka is board certified in American Board Of Ophthalmology. Dr. Repka is currently accepting new patients.

Melody Carter is a Pediatrics provider practicing medicine in Bethesda, Maryland. Dr. Carter is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Mast Cell Activation Syndrome (MCAS), Alpha-gal Syndrome (AGS), and Diarrhea. Dr. Carter is currently accepting new patients.

Dr. Lauren Melissa Jansson is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include drug abuse research, drug-exposed infants and children, and pediatrics. Dr. Jansson earned her M.D. from the State University of New York at Downstate Medical Center. She completed her residency at the Children’s Hospital at Albany Medical Center and performed a fellowship in developmental pediatrics at the Albert Einstein College of Medicine. Her research interests include fetal neurobehavioral development in drug-exposed pregnancies, lactation in opioid-dependent women on medication assisted treatment, and neonatal abstinence syndrome resulting from in utero opiate and other substance exposures. Dr. Jansson is a member of several professional organizations, including the College on Problems of Drug Dependence, the Academic Pediatric Association, and the Society for Pediatric Research. Dr. Jansson is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Neonatal Abstinence Syndrome. Dr. Jansson is board certified in American Board Of Pediatrics. Dr. Jansson is currently accepting new patients.

Dr. Perrin is the Bloomberg Distinguished Professor of Primary Care in the Department of Pediatrics and the Schools of Medicine and Nursing. She has a joint appointment in the Bloomberg School of Public Health. She is a Robert Wood Johnson Clinical Scholars Fellowship Program-trained clinician investigator whose area of research expertise is patient-oriented preventive care, health services research, health disparities, and the prevention and treatment of pediatric obesity. She has also developed, disseminated, and studied many tools to help pediatricians in practice prevent and treat obesity including the color-coded BMI charts that many use in outpatient practice. She has been the lead on numerous grants (including a multi-site randomized controlled trial NIH R01 and its renewal) on obesity and children’s health. She was previously faculty at UNC (where she won the Hettleman award, the highest award for university scholarship) and Duke. She has held previous roles as Associate Vice Chancellor for Research for the University of North Carolina at Chapel Hill and Division Chief of Primary Care Pediatrics, founding Director of the Duke Center for Childhood Obesity Research, and a fellowship director of the National Clinicians Scholars Program at Duke University. She previously served as the national chair for the Academic Pediatrics Association Research Committee. Dr. Perrin is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Obesity in Children, Premature Infant, and Autism Spectrum Disorder. Dr. Perrin is board certified in American Board Of Pediatrics. Dr. Perrin is currently accepting new patients.

Colleen Cotton, MD, is a pediatric dermatologist and assistant professor who specializes in treating children with skin problems. She sees babies, children and teenagers with all types of skin conditions including acne, birthmarks, moles, eczema, psoriasis, skin infections, genetic skin problems and many others. She is particularly interested in hidradenitis suppurativa as well as blood vessel birthmarks like hemangiomas, port wine stains, and vascular anomalies. Skin problems in children are more than just skin deep, and can be emotionally and psychologically difficult for both parents and patients to deal with. Board-certified in both dermatology and pediatric dermatology, Dr. Cotton is passionate about helping patients feel confident and comfortable in their skin. She enjoys working with families to find treatments and solutions that work for them. Dr. Cotton has written numerous peer-reviewed publications and book chapters and has spoken at several national meetings. She is also an active member of the American Academy of Dermatology, Society for Pediatric Dermatology and the Pediatric Dermatology Research Alliance. She participates in clinical research to improve our understanding of both common and rare pediatric skin diseases. Dr. Cotton grew up in the greater D.C., area and graduated from college at the University of Georgia. She then completed medical school at Washington University in St. Louis in 2013. After finishing her intern year in pediatrics at St. Christopher's Hospital for Children in Philadelphia, she did a year of pediatric dermatology research at the University of California, San Diego. Dr. Cotton then completed a dermatology residency at the University of Arizona, followed by a pediatric dermatology fellowship at the Children's Hospital of Philadelphia. She practiced in South Carolina for three years before joining the team at Children's National Hospital in 2022. Publications ORCiD. Dr. Cotton is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Vascular Birthmark, Stork Bite, Aplasia Cutis Congenita, and Ectodermal Dysplasias. Dr. Cotton is board certified in American Board Of Dermatology, 2019 and American Board Of Dermatology, 2020. Dr. Cotton is currently accepting new patients.

Dr. George Capone is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. Dr. Capone is committed to research that explores the neurobiologic basis of cognitive impairment and co-morbid neurobehavioral and psychiatric disorders associated with Down syndrome. He is also a research scientist and director of the Down Syndrome Clinic and Research Center (DSCRC) at Kennedy Krieger Institute, as well as an attending physician on the institute’s comprehensive rehabilitation unit. Dr. Capone attended college at Wesleyan University and worked as a research assistant at the Dana Farber Cancer Institute in Boston before obtaining his medical degree from the University of Connecticut in 1983. After a residency and fellowship in pediatrics at the Children''s Hospital Medical Center in Cincinnati, Dr. Capone came to Baltimore in 1988 to pursue a fellowship in neurobiology research at Johns Hopkins. Dr. Capone is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Down Syndrome, Autism Spectrum Disorder, Trisomy 12 Mosaicism, and Mosaicism. Dr. Capone is currently accepting new patients.

Dr. Eric Kossoff focuses on the diagnosis and treatment of childhood seizures and epilepsy, particularly treatments other than medications such as diet and neurostimulation. He is one of the world experts on dietary treatment for epilepsy (ketogenic diet) and lectures around the world about this therapy. His specific interests include the ketogenic diet, the modified Atkins diet for children and adults, infantile spasms, benign rolandic epilepsy, the interaction of migraine headaches with epilepsy, and Sturge-Weber syndrome. Dr. Eric Kossoff is also very involved in teaching and is the Director of the Pediatric Neurology Residency Program. He is a professor of neurology and pediatrics at the Johns Hopkins University School of Medicine. He is a co-author of Treatment of Pediatric Neurologic Disorders and the 7th edition of Ketogenic Diet Therapies. Dr. Kossoff sees patients in the Johns Hopkins Outpatient Center (5th floor) in Baltimore on Tuesday afternoons and Thursday mornings. He sees patients at Green Spring Station on Wednesday afternoons. He also participates in telemedicine. Dr. Kossoff received his medical degree from SUNY at Buffalo School of Medicine in New York. He went on to complete a residency in pediatrics at Eastern Virginia Medical School in Norfolk, Virginia. He completed a second residency in child neurology and a fellowship in pediatric epilepsy and clinical neurophysiology at The Johns Hopkins Hospital in Baltimore. Dr. Kossoff is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Epilepsy, Epilepsy in Children, Absence Seizure, Endovascular Embolization, and Gastrostomy. Dr. Kossoff is board certified in American Board Of Psychiatry And Neurology. Dr. Kossoff is currently accepting new patients.

Michael Hsieh, MD, PhD, is a urologist at Children's National Hospital. Dr. Hsieh has experience in laparoscopic and robotic surgery for urologic conditions and specializes in bladder diseases affecting children and young adults. He is board-certified in urology and holds the certificate of added qualification in pediatric urology. Dr. Hsieh was recruited to Children’s National and the George Washington University to serve as Director of Transitional Urology. This joint venture is the East Coast's first clinical program dedicated to the care of adolescents and young adults with congenital urologic disorders. Many of these patients have chronic cystitis and are at increased risk of bladder cancer, diseases which dovetail with Dr. Hsieh’s research interests. Dr. Hsieh also is the Director of Research for the Division of Urology and the Associate Director for Science at the Sheik Zayed Institute for Pediatric Surgical Innovation. He runs an NIH-funded bladder biology research group. Dr. Hsieh has been a Recognized Doctor on the Healthgrades Honor Roll and Best Doctors in America. He has been featured several times in the New York Times for his work in robotic surgery and bladder inflammation. He attended Stanford University and returned to the East Coast for medical school at Thomas Jefferson University. During medical school, Dr. Hsieh also obtained a PhD in immunology and afterwards began exploring what would eventually become his long-term interest – the role of bladder inflammation in urinary tract infections and development of bladder cancer. He completed his urology residency training at the University of California San Francisco and pediatric urology fellowship training at Texas Children’s Hospital. As a pediatric urology fellow, Dr. Hsieh began studying how the commensal microbiome (the collection of naturally occurring, non-pathogenic bacteria in and on our bodies) may prevent urinary tract infections. Following fellowship training, he was an Assistant Professor at Stanford University, where he founded an NIH-funded research group focused on bladder inflammation, urinary tract infections and bladder cancer. Dr. Hsieh was the Administrative Director for Stanford’s Children’s Hospital Prenatal Urology and Minimally Invasive Surgery Programs. Publications Google Scholar|ORCiD. Dr. Hsieh is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection (UTI), Undescended Testicle, Asymptomatic Bacteriuria, Trabeculectomy, and Orchiectomy. Dr. Hsieh is board certified in Urology: American Board Of Urology, 2012 and Pediatric Urology: American Board Of Urology, 2012.

Stephen Chanock is a Pediatrics provider practicing medicine in Potomac, Maryland. Dr. Chanock is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Mosaicism, Menopause, Gliomatosis Cerebri, Esophageal Cancer, and Hormone Replacement Therapy (HRT).

Leslie Castelo-Soccio, MD, PhD, is a dermatologist at Children's National Hospital and professor of Pediatrics and Dermatology at the George Washington University School of Medicine and Health Sciences. She is an expert in hair disorders most notably alopecia areata as well as other autoimmune skin diseases. Her interests and expertise include hair, genetic skin disorders, neonatal dermatology, inflammatory skin diseases such as eczema/atopic dermatitis and psoriasis, pigmented lesions (moles), acne and vascular disorders. She is an expert in laser and surgical treatment for pediatric patients and provides services in the clinic and operating room. Dr. Castelo-Soccio has built a research career in alopecia and inflammatory skin disease and runs clinical trials on these diseases at Children's National. Dr. Castelo-Soccio has published extensively including peer-reviewed articles and book chapters on pediatric and medical dermatology. She is a national and international speaker on hair disorders and autoimmune skin disease. She is a member of the board of directors of the American Hair Research Association and has worked closely as a volunteer for the National Alopecia Areata Foundation and the Pediatric Dermatology Research Alliance. Dr. Castelo-Soccio received her bachelor's degree with honors in biological sciences from Harvard University and her MD and PhD from Cornell University - Weill Medical College. She completed residency training in dermatology at the University of Pennsylvania and her fellowship training in pediatric dermatology at the Children's Hospital of Philadelphia. She is board certified in dermatology and pediatric dermatology. From 2011-2021 she was an attending physician at Children's Hospital of Philadelphia. From 2021-2025 she was an attending physician and researcher at the National Institutes of Health, where she still serves as a special volunteer. Dr. Castelo-Soccio is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Discoid Lupus Erythematosus (DLE), Aplasia Cutis Congenita, Ectodermal Dysplasias, and Clouston Syndrome. Dr. Castelo-Soccio is board certified in American Board Of Dermatology, 2012 and Dermatology: American Board Of Dermatology, 2009. Dr. Castelo-Soccio is currently accepting new patients.

Dr. Kathryn Lemberg is an Assistant Professor of Oncology and Pediatrics at the Sidney Kimmel Comprehensive Cancer Center. Her research, conducted with Johns Hopkins Drug Discovery, focuses on tumor metabolism and the development of new metabolic inhibitors to treat cancer. She has investigated novel glutamine antagonists in preclinical models of RAS-driven solid tumors. She is also interested in the effects of tumor metabolism on patient growth and development. Dr. Lemberg completed pediatrics residency training at Johns Hopkins and pediatric hematology-oncology fellowship training in the joint Johns Hopkins/National Cancer Institute program. She received her M.D. and Ph.D. degrees from the Medical Scientist Training Program at Columbia University in New York, where her graduate research focused on ferroptosis, a novel oxidative cell death in cancer models. Dr. Lemberg sees pediatric and young adult sarcoma patients as part of the sarcoma team and has additional clinical focus on neurofibromatosis type I related solid tumors. Dr. Lemberg is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Neurofibromatosis Type 1 (NF1), and Neurofibromatosis. Dr. Lemberg is board certified in American Board Of Pediatrics. Dr. Lemberg is currently accepting new patients.

Hemant Sharma, MD, MHS, is the Chief of the Division of Allergy and Immunology at Children’s National. He is an Associate Professor of Pediatrics at George Washington University School of Medicine, and the Director of the Food Allergy Program at Children’s National. He has served as the site director of the allergy immunology fellowship program with the National Institutes of Health. He is Director of the FARE (Food Allergy Research & Education) Clinical Network site at Children’s National. Dr. Sharma completed medical school at Columbia University College of Physicians and Surgeons, residency and chief residency at Duke University and pediatric allergy and immunology fellowship at Johns Hopkins. During fellowship, he completed a Masters in Clinical Epidemiology at the Johns Hopkins Bloomberg School of Public Health, as well as a fellowship in Health Media at Nemours. He joined the faculty at Children’s National in 2008. His areas of clinical, advocacy and research interest include racial and socioeconomic health disparities and community-based management of food allergy. He writes a quarterly column in Allergic Living magazine and answers readers’ food allergy questions. He is heavily involved in advocacy, participating in regional and national legislative efforts to improve the health of the food allergy community. Dr. Sharma is board-certified in Pediatrics and in Allergy and Immunology, and is a fellow of the American Academy of Allergy, Asthma and Immunology, serving on the Adverse Reactions to Foods Committee. Due to his efforts on behalf of the food allergy community, he was selected to receive the 2016 FARE Vision Award. Dr. Sharma is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Food Allergy, Anaphylaxis, Asthma, Knee Replacement, and Splenectomy. Dr. Sharma is board certified in Pediatrics: American Board Of Pediatrics, 2004 and Allergy And Immunology: American Board Of Allergy And Immunology, 2008.

Dr. Cohen is Director of Pediatric Neuro-Oncology and Clinical Director of the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He received his undergraduate degree at Brown University and earned his MD at the Upstate Medical University, in Syracuse, NY. He did his general Pediatric Residency and Chief Residency at the University of Colorado and completed his Pediatric Hematology/Oncology Fellowship at Johns Hopkins. He has served on the faculty since 1994. His research centers on clinical trials of novel therapeutics for children with brain tumors. Dr. Cohen is co-chair of the High-Grade Glioma committee for the Children's Oncology Group and in that capacity has a particular research interest in the development of therapeutics for the treatment of infiltrating gliomas. He serves on the scientific advisory board for a number of organizations including St. Baldricks and the Childhood Brain Tumor Foundation. He is on the editorial board for PDQ with responsibility for authorship of the pediatric CNS brain tumor summaries. The Pediatric Neuro-Oncology program conducts a broad range of research centered primarily around the development and testing of novel therapeutics for children with brain tumors. The multidisciplinary nature of this work translates into continual collaboration with specialists in pediatric neurosurgery, radiation oncology, neuropathology, neuroradiology, neurology, neuro-ophthalmology, neuropsychology, and other related disciplines. Dr. Cohen is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Gliomatosis Cerebri, Embryonal Tumor with Multilayered Rosettes, Hepatoblastoma, Infantile Neutropenia, and Bone Marrow Aspiration. Dr. Cohen is board certified in American Board Of Pediatrics. Dr. Cohen is currently accepting new patients.

Dr. John P. Gearhart is a professor of pediatrics and urology at the Johns Hopkins School of Medicine. His clinical and surgical interests focus on the evaluation and treatment of children born with major congenital birth defects, bladder exstrophy, disorders of sexual development and childhood urinary cancers. Dr. Gearhart received his M.D. from the University of Louisville School of Medicine in 1975. After an internship in surgery and residencies in surgery and urology at the Medical College of Georgia, he completed a fellowship in pediatric urology at Alder Hey Children's Hospital of the University of Liverpool School of Medicine in 1981. Following two years as a urologist at St. Mary's Hospital in Huntington, West Virginia, he completed a second fellowship in pediatric urology at Johns Hopkins in 1985 and joined the Johns Hopkins faculty thereafter as an associate professor of pediatric urology. Over the course of his distinguished career, Dr. Gearhart has been lauded as a pioneer in pediatric urology and reconstructive genitourinary surgery. He has published extensively and has received numerous awards and guest lectureships. He is a member of several national and international professional organizations and is a founding member of the Society of Reconstructive Genitourinary Surgeons. Dr. Gearhart is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Omphalocele, Umbilical Hernia, Neurogenic Bowel, Osteotomy, and Bladder Reconstruction. Dr. Gearhart is currently accepting new patients.

Courtney L. Kraus, M.D., is Knights Templar Eye Foundation Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Kraus specializes in pediatric ophthalmology and adult strabismus, including amblyopia (lazy eye), with a particular interest in pediatric cataract and corneal diseases. She has enjoyed participating in surgical mission trips to underserved areas in the developing world. Dr. Kraus received her medical degree from Washington University in St. Louis, Missouri, where she also completed her residency in ophthalmology after an internship in internal medicine at St. John’s Mercy Medical Center in Creve Coeur, Missouri. She then completed a fellowship in pediatric ophthalmology and adult strabismus at the Storm Eye Institute at The Medical University of South Carolina. Dr. Kraus is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Idiopathic Short Stature (ISS), Short Stature (Growth Disorders), Ocular Hypertension (OHT), Vitrectomy, and Cataract Removal. Dr. Kraus is board certified in American Board Of Ophthalmology. Dr. Kraus is currently accepting new patients.